Drug Databases and Their Contributions to Drug Repurposing

Drug Databases and Their Contributions to Drug Repurposing Publisher Pubmed

Masoudisobhanzadeh Y¹ ; Omidi Y² ; Amanlou M³ ; Masoudinejad A¹

Source: Genomics Published:2020

Abstract

Drug repurposing is an interesting field in the drug discovery scope because of reducing time and cost. It is also considered as an appropriate method for finding medications for orphan and rare diseases. Hence, many researchers have proposed novel methods based on databases which contain different information. Thus, a suitable organization of data which facilitates the repurposing applications and provides a tool or a web service can be beneficial. In this review, we categorize drug databases and discuss their advantages and disadvantages. Surprisingly, to the best of our knowledge, the importance and potential of databases in drug repurposing are yet to be emphasized. Indeed, the available databases can be divided into several groups based on data content, and different classes can be applied to find a new application of the existing drugs. Furthermore, we propose some suggestions for making databases more effective and popular in this field. © 2019

Related Docs

View other Related Docs

1. Drugr+: A Comprehensive Relational Database for Drug Repurposing, Combination Therapy, and Replacement Therapy, Computers in Biology and Medicine (2019)

2. Trader As a New Optimization Algorithm Predicts Drug-Target Interactions Efficiently, Scientific Reports (2019)

3. Computational Prediction of Drug-Drug Interactions Based on Drugs Functional Similarities, Journal of Biomedical Informatics (2017)

Experts (# of related papers)

View all Related Experts

Reza Safdari (3)

Massoud Amanlou (2)

Style	Citing Format
MLA	Masoudisobhanzadeh Y, et al.. "Drug Databases and Their Contributions to Drug Repurposing." Genomics, vol. 112, no. 2, 2020, pp. 1087-1095.
APA	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A (2020). Drug Databases and Their Contributions to Drug Repurposing. Genomics, 112(2), 1087-1095.
Chicago	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A. "Drug Databases and Their Contributions to Drug Repurposing." Genomics 112, no. 2 (2020): 1087-1095.
Harvard	Masoudisobhanzadeh Y et al. (2020) 'Drug Databases and Their Contributions to Drug Repurposing', Genomics, 112(2), pp. 1087-1095.
Vancouver	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A. Drug Databases and Their Contributions to Drug Repurposing. Genomics. 2020;112(2):1087-1095.
BibTex	@article{ author = {Masoudisobhanzadeh Y and Omidi Y and Amanlou M and Masoudinejad A}, title = {Drug Databases and Their Contributions to Drug Repurposing}, journal = {Genomics}, volume = {112}, number = {2}, pages = {1087-1095}, year = {2020} }
RIS	TY - JOUR AU - Masoudisobhanzadeh Y AU - Omidi Y AU - Amanlou M AU - Masoudinejad A TI - Drug Databases and Their Contributions to Drug Repurposing JO - Genomics VL - 112 IS - 2 SP - 1087 EP - 1095 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract